Pembrolizumab-induced vasculitis demonstrated by FDG-PET/CT

Pembrolizumab-induced vasculitis demonstrated by FDG-PET/CT

A 76-year-old man with a history of malignant pleural mesothelioma treated with pembrolizumab underwent FDG-PET/CT for restaging. The images demonstrated FDG uptake overlying the right hepatic and splenic artery, which were new from the previous FDG-PET/CT 2.5 years prior before the patient started...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Tuan Vu, BS, Sophia R. O'Brien, MD, Shawn X. Ma, MD, Karthik M. Sundaram, MD, PhD, Austin R. Pantel, MD, MSTR
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Elsevier 2024-09-01
Sarja:Radiology Case Reports
Aiheet:
PET imaging
FDG
Vasculitis
Pembrolizumab
Immune checkpoint inhibitors
Linkit:http://www.sciencedirect.com/science/article/pii/S1930043324005235

Internet

http://www.sciencedirect.com/science/article/pii/S1930043324005235

Samankaltaisia teoksia